Code Bio
is a Pennsylvania-based biotechnology company that develops and commercializes non-viral gene therapies for the treatment of rare diseases... Read moreCode Bio
is a Pennsylvania-based biotechnology company that develops and commercializes non-viral gene therapies for the treatment of rare diseases... Read more
News
Jun 17, 2022
Global Legal Chronicle
Code Bio: Code Biotherapeutics' $75 Million Series A Financing
Jun 08, 2022
FinSMEs
Code Bio: Code Biotherapeutics Raises $75 Million in Series A Financing
Jun 07, 2022
BioSpace
Code Bio: Code Bio Launches with $75M to Disrupt Gene Therapy Space
Jun 07, 2022
MedCity News
Code Bio: Code Bio corrals $75M to skip viruses, use synthetic DNA for genetic meds delivery
Feb 23, 2022
Pharamceutical Technology
Code Bio: Code Bio and Takeda collaborate to develop gene therapies for rare diseases
Dec 02, 2021
firstword pharma
Code Bio: Code Biotherapeutics Appoints Erin Brubaker as COO
Apr 20, 2021
Drug Delivery Business
Code Bio: Code Biotherapeutics launches with $10M seed financing
